APAC Market Entry & Business Expansion

uilt profitable excipient businesses across India, Korea, Japan, and ASEAN. Achieved double-digit revenue growth and gross margin protection through targeted distributor networks, regulatory pathways (USFDA DMF, FSSAI, Schedule M), and customer-centric value selling.